Coronavirus

Chart Industries and AG Gas Sign Memorandum of Understanding for CO2 Enrichment in Agriculture

Retrieved on: 
Thursday, August 11, 2022
Nexus, Carbon dioxide, Ventilation, Carbon, CEO, NYSE, GLOBE, Forward-looking statement, Technology, Private Securities Litigation Reform Act, Growth, SEC, Hydrogen, AG, Annual report, Light, ESG, Marketing, COVID-19, Food, CO2, Partnership, Safety, Water, Natural gas, Nature, Coronavirus, Risk, Solution, Photosynthesis, Chart, Efficiency, Temperature, Terminology, Renewable energy

AG Gas CO2 enrichment systems and Chart cryogenic tanks are already being deployed together in the California market.

Key Points: 
  • AG Gas CO2 enrichment systems and Chart cryogenic tanks are already being deployed together in the California market.
  • Chart has already proven to be a great partner to AG Gas as weve begun to develop the market for our CO2 enrichment technology, according to Barry Nadler, AG Gas President and CEO.
  • Weve been impressed with the sophistication and effectiveness of the AG Gas technology, said Jillian Evanko, President and CEO of Chart.
  • Offered as a turnkey solution, AG Gas installs, maintains and monitors its systems to ensure safe and cost-effective application of CO2.

Interim results for the period ended June 30, 2022

Retrieved on: 
Thursday, August 11, 2022
U.S. Securities and Exchange Commission, Form 20-F, Klaipėda LNG FSRU, Snam, Securities Exchange Act of 1934, Progress Energy Inc, Investment, Security (finance), Knowledge, Company, Contract, Mission statement, Commission, Pandemic, Natural gas, Coronavirus, Weakness, Prelude FLNG, Annual report, Mount Gimie, Golar Spirit, Audit, LNG, FLNG, NFE

Earnings Backlog: Earnings backlog represents the share of contracted fee income for executed contracts less forecasted operating expenses for these contracts.

Key Points: 
  • Earnings Backlog: Earnings backlog represents the share of contracted fee income for executed contracts less forecasted operating expenses for these contracts.
  • Therefore, actual outcomes and results may differ materially from what is expressed or forecasted in such forward-looking statements.
  • Actual results may differ materially from those expressed or implied by such forward-looking statements.
  • To the best of our knowledge, the interim report for the first half year of 2022 includes a fair review of important events that have occurred during the period and their impact on the interim consolidated financial statements, the principal risks and uncertainties for the remaining half of 2022, and major related party transactions.

DGAP-News: Biotest AG: Biotest achieves an improved adjusted EBIT by 9.8% of EUR 32.4 million in the first half of 2022

Retrieved on: 
Thursday, August 11, 2022
Factor I deficiency, EBIT, Fibrinogen, Half-year convention, SCAP, Board of directors, Policy, Phenotypic trait, Board, Director, Research, Plasma, Patient, EBITDA, COVID-19, Board of Management St. Molaga's National School v The Secretary General of the Department of Education and Science, Management, Depreciation, Tax, Next Level, Coronavirus, Antibody, Time, III, Federal Executive Boards, Video game, Renewable energy, Pharmaceutical industry, Fine chemical

Earnings before interest, taxes, depreciation and amortisation (EBITDA) amounted to 8.8 million in the first half of the 2022 financial year, compared to 5.8 million in the first half of the previous year.

Key Points: 
  • Earnings before interest, taxes, depreciation and amortisation (EBITDA) amounted to 8.8 million in the first half of the 2022 financial year, compared to 5.8 million in the first half of the previous year.
  • EBIT in the first half of the year 2022 mounted to - 9.1 million and was thus below the previous year's value of - 8.5 million.
  • In the current half year, this includes expenses for the Biotest Next Level project in the amount of 41.5 million (same period of the previous year: 38.0 million).
  • The Biotest Group's total earnings after tax in the first half of 2022 were -19.9 million (same period of the previous year: -18.2 million).

DGAP-News: Berentzen-Gruppe Aktiengesellschaft publishes Group Half-yearly Financial Report

Retrieved on: 
Thursday, August 11, 2022
EBIT, General Standard, Pushkin, Growth, EUR, ISIN, Group, Sinalco, Fruit, EBITDA, Frankfurt Stock Exchange, Depreciation, Tax, Mineral, Coronavirus, Mission statement, Friedrich Berentzen, Film

Haselnne, August 11, 2022 Berentzen-Gruppe Aktiengesellschaft, which is listed on the regulated market (General Standard) of the Frankfurt Stock Exchange (ISIN: DE0005201602), today published its Group Half-yearly Financial Report.

Key Points: 
  • Haselnne, August 11, 2022 Berentzen-Gruppe Aktiengesellschaft, which is listed on the regulated market (General Standard) of the Frankfurt Stock Exchange (ISIN: DE0005201602), today published its Group Half-yearly Financial Report.
  • The Berentzen Group thus confirms the provisional figures it had already made public in a mandatory capital market announcement on July 12, 2022.
  • Revenues have returned to the level of the first half of a financial year prior to the coronavirus pandemic.
  • The Berentzen-Gruppe Aktiengesellschaft share (ISIN DE0005201602) is listed on the regulated market (General Standard) of the Frankfurt Stock Exchange.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Enochian, Weber, and Coinbase and Encourages Investors to Contact the Firm

Retrieved on: 
Thursday, August 11, 2022
Seraph, HIV, Bankruptcy, Disclosure, Risk, NYSE, Â, GLOBE, Georgetown University Law Center, Technology, Ecosystem, Hindenburg Research, Coinbase, SEC, Weber, WEBR, Bloomberg, Cancer, SRI, LLC, Defendant, Texas Law Review, Coronavirus, U.S. Department of Justice Office of Legislative Affairs, U.S. Department of Defense Strategy for Operating in Cyberspace, Company, Lists of schools in England, G-Technology, Credit risk, Register, Fraud, Hindenburg, NASDAQ, News, Science, For Hire, Hepatitis B virus, Registration statement, China Biologic Products, IPO, Justice, Complaint, Identity theft, Private investigator, Renewable energy, Pharmaceutical industry, Audit, Security (finance), Cryptocurrency, P.C, Enochian

On May 25, 2022, the U.S. Department of Justice announced that Gumrukcu had been arrested and charged in a murder-for-hire conspiracy.

Key Points: 
  • On May 25, 2022, the U.S. Department of Justice announced that Gumrukcu had been arrested and charged in a murder-for-hire conspiracy.
  • On this news, Enochians stock price fell $2.17 per share, or 36.97%, to close at $3.70 per share on May 25, 2022.
  • For more information on the Coinbase class action go to: https://bespc.com/cases/COIN
    About Bragar Eagel & Squire, P.C.
  • The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.

Track Group Reports 3rd Quarter Fiscal 2022 Financial Results

Retrieved on: 
Thursday, August 11, 2022
U.S. Securities and Exchange Commission, Disclosure, Risk, Travel, Income, CEO, Technology, Growth, Securities Exchange Act of 1934, Telecommunication, Q3, Law enforcement, Security (finance), Adjustment, EBITDA, Company, Depreciation, Form 10-K, Tax, Exchange, Adjusting entries, PPP, Insurance, Software, Private Securities Litigation Reform Act, Time, Annual report, OTCQX, Forgiveness, Renewable energy, Bookkeeping, Bank, Mobile phone, Risk management, Coronavirus

NAPERVILLE, Ill., Aug. 10, 2022 /PRNewswire/ -- Track Group, Inc. (OTCQX: TRCK), a global leader in offender tracking and monitoring services, today announced financial results for its third quarter ended June 30, 2022 ("Q3 FY22").

Key Points: 
  • NAPERVILLE, Ill., Aug. 10, 2022 /PRNewswire/ -- Track Group, Inc. (OTCQX: TRCK), a global leader in offender tracking and monitoring services, today announced financial results for its third quarter ended June 30, 2022 ("Q3 FY22").
  • However, we will not match our results for the fiscal year ended September 2021 ("FY21") in the upcoming year ending September 30, 2022 ("FY22").
  • This release includes financial measures defined as "non-GAAP financial measures" by the Securities and Exchange Commission including non-GAAP EBITDA.
  • Specific disclosure regarding the Company's financial results, including management's analysis of results from operations and financial condition, are contained in the Company's annual report on Form 10-K for the fiscal year ended September 30, 2021, and other reports filed with the Securities and Exchange Commission.

Kite Realty Group Trust Declares Quarterly Common Dividend of $0.22 per Common Share, a 5% Increase Over Previous Quarter and a 22% Year-over-Year Increase

Retrieved on: 
Wednesday, August 10, 2022
Epidemic, U.S. Securities and Exchange Commission, Terrorism, Securities Act of 1933, Climate change, Risk, Lists of disasters, Industry, NYSE, GLOBE, Growth, Securities Exchange Act of 1934, Investment, Fear, KRG, Board, Security (finance), Annual report, Environment, Government, Board of directors, COVID-19, Company, NOI, Acquisition, Pandemic, REIT, Coronavirus, Form 10-Q, Consumer, Ownership, Insurance, Trustee, Weather, Risk management, Sun Belt

INDIANAPOLIS, Aug. 10, 2022 (GLOBE NEWSWIRE) -- Kite Realty Group Trust (NYSE: KRG) announced today that its Board of Trustees declared a quarterly cash distribution of $0.22 per common share for the quarter ending September 30, 2022.

Key Points: 
  • INDIANAPOLIS, Aug. 10, 2022 (GLOBE NEWSWIRE) -- Kite Realty Group Trust (NYSE: KRG) announced today that its Board of Trustees declared a quarterly cash distribution of $0.22 per common share for the quarter ending September 30, 2022.
  • This distribution will be paid on or about October 14, 2022, to shareholders of record as of October 7, 2022.
  • Kite Realty Group Trust (NYSE: KRG) is a real estate investment trust (REIT) headquartered in Indianapolis, IN that is one of the largest publicly traded owners and operators of open-air shopping centers and mixed-use assets.
  • The companys primarily grocery-anchored portfolio is located in high-growth Sun Belt and select strategic gateway markets.

ADMA Biologics Announces Second Quarter 2022 Financial Results and Provides Business Update

Retrieved on: 
Wednesday, August 10, 2022
Shift, U.S. Securities and Exchange Commission, GLOBE, SEC, Patent, Method, Marketing, Patient, PIN, European Patent Office, Infection, Urinary tract infection, Collection, Disease, Metapneumovirus, Sex linkage, Risk, Private Securities Litigation Reform Act, Environment, Respiratory syncytial virus, Increase, Conference, Immunity, San Jose BioCenter, Forward-looking statement, Growth, Income, General manager, ADMA, 8-K, Lists of diseases, IVIG, Morgan Stanley, Coronavirus, Virus, FDA, Antibody, Immunodeficiency, RSV, PIDD, Immunoglobulin therapy, Plasma, Company, Bacteria, Wiskott–Aldrich syndrome, United States Patent and Trademark Office, Protein, Hepatitis B virus, Food and Drug Administration, Adoption, Video game, Renewable energy, Vaccine, Medical device, Tutoring, PI

ET

Key Points: 
  • ET
    RAMSEY, N.J. and BOCA RATON, Fla., Aug. 10, 2022 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (ADMA or the Company), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologics, today announced its second quarter 2022 financial results and provided a business update.
  • Second Quarter 2022 and Recent Achievements:
    Significant Revenue Growth: Achieved second quarter 2022 total revenues of $33.9 million, as compared to $17.8 million during the second quarter of 2021, an increase of $16.1 million, or approximately 90%.
  • 2022 & Long-Term Financial Guidance:
    2022 Financial Guidance: Enabled by the strong start to the year, ADMA anticipates total 2022 revenues will exceed $130 million.
  • Second Quarter 2022 Financial Results:
    Total revenues for the second quarter ended June 30, 2022 were $33.9 million, as compared to $17.8 million during the second quarter of 2021, an increase of $16.1 million, or approximately 90%.

Macquarie/First Trust Global Infrastructure/Utilities Dividend & Income Fund Declares its Quarterly Distribution of $0.20 Per Share

Retrieved on: 
Wednesday, August 10, 2022
Banking, Professional Services, Finance, Movement, Terrorism, Debt-to-GDP ratio, Union, New York Stock Exchange, Risk, ERISA, FINRA, Travel, Internal Revenue Code, NYSE, Fund, MAM, Technology, FERC, Investment, Policy, MLP, London Interbank Bid Rate, Internal Revenue Code section 409A, Macquarie Group, Income, Instability, Review, Asset-backed security, AIB (NI), COVID-19, Infection, NAV, Acquisition, Judgement, Capital gain, Federal Energy Regulatory Commission, Adviser, Vaccine, Coronavirus, MFD, Hedge fund, Financial Conduct Authority, Loss, Ownership, FTP, Core Component Technical Specification, FTA, Weather, LIBOR, Natural Resources, Disease, Renewable energy, Life insurance, Security (finance), Financial adviser, Financial services, Bank, Brexit

Macquarie/First Trust Global Infrastructure/Utilities Dividend & Income Fund (the "Fund") (NYSE: MFD) has declared the Fund's regularly scheduled quarterly distribution of $0.20 per share.

Key Points: 
  • Macquarie/First Trust Global Infrastructure/Utilities Dividend & Income Fund (the "Fund") (NYSE: MFD) has declared the Fund's regularly scheduled quarterly distribution of $0.20 per share.
  • FTA and its affiliate First Trust Portfolios L.P. ("FTP"), a FINRA registered broker-dealer, are privately-held companies that provide a variety of investment services.
  • FTP is also a distributor of mutual fund shares and exchange-traded fund creation units.
  • The Fund principally invests in a global portfolio of infrastructure stocks in a range of currencies and senior secured loans.

First Trust Specialty Finance and Financial Opportunities Fund Declares its Quarterly Distribution of $0.0825 Per Share

Retrieved on: 
Wednesday, August 10, 2022
Banking, Professional Services, Finance, Terrorism, Internal Revenue Code, New York Stock Exchange, Risk, ERISA, FINRA, Travel, Industry, NYSE, Fund, Technology, SEC, Investment, Internal Revenue Code section 1031, BDC, Income, Confluence, Review, AIB (NI), COVID-19, Infection, FGB, Judgement, Capital gain, Adviser, Vaccine, Coronavirus, Loss, FTP, FTA, Disease, Life insurance, Security (finance), Financial adviser, Bank

First Trust Specialty Finance and Financial Opportunities Fund (the "Fund") (NYSE: FGB) has declared the Fund's regularly scheduled quarterly distribution of $0.0825 per share.

Key Points: 
  • First Trust Specialty Finance and Financial Opportunities Fund (the "Fund") (NYSE: FGB) has declared the Fund's regularly scheduled quarterly distribution of $0.0825 per share.
  • The Fund is a diversified, closed-end management investment company that seeks to provide a high level of current income.
  • First Trust Advisors L.P. ("FTA") is a federally registered investment advisor and serves as the Fund's investment advisor.
  • FTA and its affiliate First Trust Portfolios L.P. ("FTP"), a FINRA registered broker-dealer, are privately-held companies that provide a variety of investment services.